C12N 2770/24231
Uses of virus other than therapeutic or vaccine
Official title: Uses of virus other than therapeutic or vaccine, e.g. disinfectant
C12N2770/24231 (Uses of virus other than therapeutic or vaccine) appears on 4 US grants and 6 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 6
- Assignees
- 10
- Inventors
- 22
- Latest grant
- 13 Feb 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 2 |
| 2014 | 2 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Compositions and methods for simultaneous detection of HCV antigen/antibody13 Feb 2018US 9,891,225 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Nucleic acid construct comprising nucleic acid derived from genome of hepatitis C virus of genotype 1B, hepatitis C virus genome-replicating cells transfected with the same, and method for producing infectious hepatitis C virus particles12 Jan 2016US 9,234,184 B2Japan AS Represented By Director-General of National Institute of Infectious Diseases
- HCV genotype 3 replicons18 Nov 2014US 8,889,848 B2Gilead Sciences, Inc.
- HCV genotype 4 replicons18 Nov 2014US 8,889,849 B2Gilead Sciences, Inc.
- Efficient cell culture system for hepatitis c virus genotype 4a3 Oct 2024US 2024/0327801 A1Hvidovre Hospital
- Camelid single-domain hcv antibodies and methods of use11 Oct 2018US 2018/0292408 A1Qoolabs, Inc.
- Compositions and methods for simultaneous detection of hcv antigen/antibody21 Apr 2016US 2016/0109451 A1The U.S.A., AS Represented By the Secretary, Depa- Rtment of Health and Human Services
- Nucleic acid construct comprising nucleic acid derived from genome of hepatitis c virus of genotype 1b, hepatitis c virus genome-replicating cells transfected with the same, and method for producing infectious hepatitis c virus particles9 Oct 2014US 2014/0302082 A1Japan AS Represented By the Director-General of National Institute of Infectious Disease
- Hcv genotype 3 replicons28 Feb 2013US 2013/0052633 A1Gilead Sciences, Inc.
Most cited
By later US patents